Building Bridges 2026 happening in:
0 Days
0 Hours
0 Minutes
0 Seconds
Learn more

Reme-D

Contact the Organiser

Please note that the contents of this contact form are subject to moderation. If the organisation chooses to respond, all future correspondence will be directly between your respective email accounts and will not be subject to moderation via this site.

Please tick the checkbox to prove that you are human.

Ensure that you are using either the latest or preceding version of IE/Edge, Chrome, Firefox or Safari.
The security captcha challenge has been expired, please retry.
There was an error during security captcha verification, please retry.

Bringing accessible disease diagnostics to underserved markets.

Reme-D tackles limited availability and affordability of diseases diagnostics in Africa and global South, by locally developing & manufacturing diagnostic tests for regional needs. Leveraging proprietary technology, we develop and produce accurate diagnostic tests that are 6x more affordable, 3x faster, and simpler than mainstream products. They’re also temperature-resilient to be transported without need for cold-chain logistics to reach remote last-mile users. Amid shrinking global healthcare funding, Reme-D maximizes limited resources, delivering greater value and health equity for all.

Business model description: We sell our locally-made diagnostic tests to medical & research labs, blood banks (B2B & B2G), directly or on consignment agreements with our diagnostic equipment. They’re ~6x more affordable, 3x faster, as effective as competitors, and temperature-resilient to access to resource-limited settings.

Themes: Health

Regions/Countries of activity or interest: Egypt, Kenya, Sudan, Africa and Global South

Organisation HQ: Egypt

Fundraising Stage: Series A

Business Model: B2B

Fundraising Capital type: Equity



The information presented on this page has been provided by the participating organisation. Building Bridges publishes this information for general informational purposes in connection with Building Bridges 2026. Building Bridges has not independently verified the information and does not endorse any organisation, product, service, strategy, or claim described herein.